Page last updated: 2024-11-02

pioglitazone and Chronic Esophagitis, Eosinophilic

pioglitazone has been researched along with Chronic Esophagitis, Eosinophilic in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nhu, QM1
Hsieh, L1
Dohil, L1
Dohil, R1
Newbury, RO1
Kurten, R1
Moawad, FJ1
Aceves, SS1

Other Studies

1 other study available for pioglitazone and Chronic Esophagitis, Eosinophilic

ArticleYear
Antifibrotic Effects of the Thiazolidinediones in Eosinophilic Esophagitis Pathologic Remodeling: A Preclinical Evaluation.
    Clinical and translational gastroenterology, 2020, Volume: 11, Issue:4

    Topics: Biopsy; Budesonide; Cells, Cultured; Drug Evaluation, Preclinical; Eosinophilic Esophagitis; Esophag

2020